Point of Care Diagnostics Market Size and Forecast 2026–2034

The global Point of Care Diagnostics Market is experiencing remarkable growth as healthcare systems increasingly shift toward faster, more accessible diagnostic solutions. According to Renub Research, the market is expected to expand from US$ 50.41 Billion in 2025 to US$ 100.94 Billion by 2034, growing at a Compound Annual Growth Rate (CAGR) of 8.02% from 2026 to 2034.

This rapid expansion is fueled by several factors including the rising prevalence of infectious and chronic diseases, increasing demand for rapid diagnostic solutions, and the growing adoption of home healthcare technologies. Technological advancements in portable diagnostic devices and improved healthcare accessibility in remote and rural areas are also contributing significantly to the growth of the Point of Care (POC) diagnostics industry.

Point of Care Diagnostics Industry Overview

Point of Care Diagnostics refers to medical tests performed at or near the patient’s location, eliminating the need to send samples to centralized laboratories. These tests can be conducted in hospitals, clinics, ambulances, doctor's offices, pharmacies, or even within patients’ homes.

Unlike traditional laboratory testing—where results may take hours or days—POC diagnostics deliver rapid results within minutes, enabling healthcare professionals to make immediate clinical decisions.

Common examples of POC diagnostic tests include:

Blood glucose monitoring

Pregnancy tests

Rapid COVID-19 antigen tests

Cardiac marker testing

Infectious disease screening

These tests utilize portable and easy-to-operate diagnostic devices designed to detect a wide range of medical conditions such as infections, metabolic disorders, and chronic diseases.

The growing adoption of POC diagnostics worldwide is largely attributed to its speed, convenience, and clinical efficiency. Faster test results enable quicker treatment decisions, which improves patient outcomes while reducing healthcare system burden.

In addition, point-of-care diagnostics significantly enhance patient convenience by reducing hospital visits and waiting times. These diagnostic solutions are particularly valuable in emergency settings, remote areas, and developing countries where access to centralized laboratory infrastructure is limited.

As healthcare systems increasingly prioritize early detection, preventive care, and decentralized healthcare models, POC diagnostics are becoming an integral part of modern medical practice.

Growth Drivers of the Point of Care Diagnostics Market

Rising Prevalence of Chronic and Infectious Diseases

One of the primary factors driving the growth of the Point of Care Diagnostics Market is the increasing global burden of chronic and infectious diseases.

According to the Centers for Disease Control and Prevention (CDC), congenital heart defects represent the most common birth defects in the United States, affecting approximately 1% of births annually. Early detection through diagnostic testing allows for improved treatment planning and disease management.

Similarly, lifestyle changes, environmental factors, and aging populations have contributed to a surge in diseases such as:

Diabetes

Cardiovascular diseases

Respiratory disorders

Cancer

For instance, the Breast Cancer Research Foundation estimates that around 300,590 individuals were expected to be diagnosed with breast cancer in the United States in 2023.

Chronic diseases often require continuous monitoring and timely diagnosis to prevent complications. Point of care diagnostic devices provide rapid testing and instant results, allowing healthcare providers to make faster treatment decisions.

In addition, infectious diseases such as influenza, COVID-19, and various bacterial infections have increased demand for rapid diagnostic testing solutions. POC testing plays a vital role in identifying infections quickly, preventing transmission, and enabling early treatment.

The growing global geriatric population further increases the need for regular health monitoring, which strengthens the demand for portable and convenient diagnostic technologies.

Technological Advancements and Portable Diagnostic Devices

Technological innovation has dramatically improved the accuracy, efficiency, and usability of point-of-care diagnostic devices.

Modern POC diagnostic tools are now:

Highly portable

User-friendly

Capable of delivering highly accurate results within minutes

Advancements in biosensors, microfluidics, and digital health technologies have expanded the capabilities of POC devices. Some advanced diagnostic platforms can now detect multiple biomarkers simultaneously, enabling comprehensive disease diagnosis using a single device.

Integration with smartphones and cloud-based healthcare systems has further enhanced the value of these devices by enabling:

Real-time data sharing

Remote patient monitoring

Digital medical record integration

Portable and wearable diagnostic devices are also gaining popularity, allowing continuous monitoring of health conditions.

A notable industry development occurred in February 2024, when Roche introduced three new coagulation assays designed for oral Factor Xa inhibitors including rivaroxaban, apixaban, and edoxaban. These assays assist clinicians in making more accurate treatment decisions for patients receiving anticoagulant therapies for stroke prevention and thromboembolism management.

These innovations make POC diagnostics more reliable, accessible, and affordable—contributing significantly to global market expansion.

Growing Demand for Home Healthcare and Decentralized Testing

Another major factor driving the market is the rising demand for home healthcare services and decentralized medical testing.

Patients increasingly prefer diagnostic solutions that can be performed at home or in nearby healthcare facilities without visiting centralized laboratories.

Home-based point-of-care devices allow individuals to monitor conditions such as:

Diabetes

Pregnancy

Infections

Cardiovascular health

This trend is particularly beneficial for elderly individuals, patients with mobility limitations, and people living in rural regions.

Healthcare systems are also encouraging decentralized testing to reduce pressure on hospitals and improve operational efficiency.

The COVID-19 pandemic significantly accelerated the adoption of home-based diagnostic testing, reinforcing the importance of rapid and accessible healthcare solutions.

In June 2025, Amazon India entered the diagnostics sector by launching a new at-home diagnostics service through its mobile application. The service enables users to book laboratory tests, manage appointments, and access digital reports conveniently.

Furthermore, the integration of telemedicine with POC diagnostic devices allows physicians to monitor patients remotely, supporting the shift toward patient-centric healthcare models.

Challenges in the Point of Care Diagnostics Market

Accuracy and Reliability Concerns

Despite its advantages, the POC diagnostics market faces several challenges—one of the most significant being concerns regarding accuracy and reliability compared with traditional laboratory testing.

Although many POC tests deliver rapid results, some may lack the sensitivity or specificity of centralized laboratory methods. This can sometimes result in:

False positive results

False negative results

Such inaccuracies may affect clinical decision-making and patient safety.

Additionally, device performance may vary depending on environmental conditions, device handling, and operator experience. In some cases, confirmatory testing in centralized laboratories may still be required.

To address these issues, manufacturers are investing heavily in research and development to improve diagnostic accuracy and device validation.

Regulatory Challenges and Skilled Workforce Limitations

The point of care diagnostics industry is also influenced by strict regulatory frameworks designed to ensure safety, accuracy, and clinical effectiveness.

Manufacturers must comply with complex regulatory approval processes before launching diagnostic devices in different countries. These requirements may delay product commercialization and increase development costs.

Regulatory standards also vary significantly across regions, making global market expansion more complicated.

Another challenge involves the lack of trained healthcare professionals capable of operating diagnostic devices correctly. While many POC devices are designed to be simple and user-friendly, proper training is still required to ensure reliable results and effective patient care.

Improving training programs and expanding awareness about POC technologies will be essential for broader adoption.

Segment Insights in the Point of Care Diagnostics Market

Point of Care Infectious Diseases Kits Market

Point of care infectious disease testing kits are designed to rapidly detect viruses, bacteria, and parasites directly at the patient’s location.

These diagnostic kits are widely used for detecting infections such as:

Influenza

COVID-19

HIV

Malaria

Dengue fever

Rapid detection enables healthcare providers to initiate treatment immediately and prevent disease outbreaks.

These kits are particularly valuable in emergency care settings, rural regions, and resource-limited healthcare systems where laboratory infrastructure may be unavailable.

With increasing global focus on disease surveillance and outbreak preparedness, the demand for infectious disease testing kits is expected to grow substantially.

Lateral Flow Point of Care Diagnostics Market

Lateral flow diagnostic devices are among the most widely used point-of-care testing technologies due to their simplicity, affordability, and rapid results.

These tests typically require small samples of blood, urine, or saliva and provide visual results within minutes.

Common examples include:

Pregnancy tests

COVID-19 rapid antigen tests

Infectious disease test strips

Lateral flow devices do not require complex laboratory equipment, making them ideal for home use, small clinics, and developing regions.

Technological advancements have improved the sensitivity and accuracy of these devices, expanding their applications across multiple healthcare settings.

Prescription-Based Point of Care Devices Market

Prescription-based point-of-care diagnostic devices are advanced tools used under the supervision of healthcare professionals.

These devices are commonly used for diagnosing and managing serious medical conditions including:

Cardiovascular diseases

Diabetes

Infectious diseases

Hospitals and healthcare facilities rely on these devices to support rapid clinical decision-making, improving treatment efficiency and patient outcomes.

Technological improvements have enhanced device portability, connectivity, and integration with digital health platforms.

As healthcare systems increasingly focus on early disease detection and personalized medicine, demand for prescription-based POC diagnostic devices is expected to continue growing.

Regional Insights

United States Point of Care Diagnostics Market

The United States represents one of the most advanced markets for point of care diagnostics due to its highly developed healthcare infrastructure and rapid adoption of innovative medical technologies.

Hospitals, clinics, and home healthcare providers widely utilize POC diagnostic devices to improve diagnostic speed and patient care.

The high prevalence of chronic diseases—including diabetes and cardiovascular disorders—continues to drive demand for rapid diagnostic solutions.

In May 2025, Siemens Healthineers announced an investment of USD 150 million to strengthen manufacturing and supply chain capabilities in the United States, further supporting the expansion of diagnostic technologies.

United Kingdom Point of Care Diagnostics Market

The United Kingdom is witnessing steady growth in POC diagnostics due to the integration of rapid testing solutions within the national healthcare system.

Hospitals, community healthcare providers, and general practitioners increasingly use POC devices to reduce laboratory workloads and enhance diagnostic efficiency.

Government initiatives aimed at modernizing healthcare infrastructure and promoting preventive care are further supporting market growth.

India Point of Care Diagnostics Market

India is emerging as a fast-growing market for point-of-care diagnostics due to rising healthcare awareness and the need for cost-effective diagnostic solutions.

Infectious diseases such as tuberculosis, dengue, and malaria remain significant public health concerns. Additionally, the growing prevalence of chronic conditions such as diabetes has increased demand for frequent diagnostic testing.

POC diagnostic devices are especially valuable in rural areas, where access to centralized laboratories may be limited.

In January 2023, Cipla introduced Cippoint, an immunofluorescence-based quantitative analyzer capable of delivering diagnostic results within 3 to 15 minutes, making it suitable for mobile healthcare units and rural clinics.

Saudi Arabia Point of Care Diagnostics Market

Saudi Arabia’s point of care diagnostics market is expanding due to increasing investments in healthcare modernization and medical technology.

Government initiatives aimed at improving healthcare accessibility and preventive care have encouraged the adoption of rapid diagnostic tools.

In October 2025, Co-Diagnostics partnered with Arabian Eagle Manufacturing to form a joint venture named CoMira Diagnostics. The partnership focuses on developing and commercializing advanced point-of-care PCR diagnostic technologies.

Competitive Landscape

The global Point of Care Diagnostics Market features several major healthcare technology companies driving innovation and market expansion.

Key players include:

Sysmex

Abbott Laboratories

Becton, Dickinson and Company

Danaher Corporation

Quidel Diagnostics

F. Hoffmann-La Roche Ltd

Thermo Fisher Scientific Inc.

Bio-Rad Laboratories Inc.

These companies compete through product innovation, strategic partnerships, technological advancements, and global expansion strategies.

Final Thoughts

The Point of Care Diagnostics Market is undergoing a transformative phase as healthcare systems move toward faster, decentralized, and patient-centered diagnostic solutions.

Rapid technological advancements, increasing chronic disease prevalence, and growing demand for home healthcare are reshaping the global diagnostics landscape.

With the market projected to double in size and reach US$100.94 Billion by 2034, point-of-care diagnostics will play an increasingly critical role in improving healthcare accessibility, accelerating disease detection, and enabling more efficient treatment decisions worldwide.

As healthcare continues to evolve toward digital, decentralized, and preventive models, point-of-care diagnostics will remain at the forefront of modern medical innovation.